Mediastinal non-seminomatous germ cell turnouts (MNSGCT) treated with cisplatin-based combination chemotherapy

Annals of Oncology

Volumn 8, Issue 6, 1997, Pages 555-559

  Hidalgo, M ^a   Paz Ares, L ^a   Rivera, F ^b   Lianes, P ^a   Huidobro, G ^c   Ruiz, A ^a   Lopez Brea M ^b   Sanz Ortiz, J ^b   López, J López ^c   Cortes Funes H ^a   Tabernero, J M ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Cisplatin based chemotherapy; Extragonadal; Germ cell tumours; Mediastinum

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GERM CELL TUMOR; HUMAN; MALE; MEDIASTINUM TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 8544229879     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008225129682     Document Type: Article

References (29)

1. Nichols CR. Mediastinal germ cell tumors clinical features and biologic correlates. Chest 1991; 99: 472-9.
2. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 322: 1425-9.
3. Nichols CR, Heerema NA, Palmer C et al. Klinefelter syndrome associated with mediastinal germ cell neoplasia. J Clin Oncol 1987; 5: 1290-4.
4. Raghavan D, Boyer MJ. Malignant extragonadal germ cell tumours in adults. In Horwich A (ed): Testicular Cancer. Philadelphia: Lippincott 1993; 297-317.
5. Willians SD, Birch R, Einhorn LH et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 1987; 316: 1435-40.
6. Rustin GJS, Newlands EW, Bagshave KD et al. Successful management of metastatic germ cell tumours in the brain. Cancer 1986; 57: 2108-13.
7. Loehrer PJ, Laver R, Roth BJ et al. Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastin or etoposide. Ann Intern Med 1988; 109: 540-6.
8. Germa-Lluch JR et al. Intensive chemotherapy in poor prognosis non-seminomatous germ cell tumours of the testis. Eur Urol 1992; 21: 287-93.
9. Bosl GJ, Gluckman R, Geller NL et al. VAB-6: An effective chemotherapy regimen for patients with germ cell tumors. J Clin Oncol 1986; 4: 1493-9.
10. Motzer RJ, Bajorin DF, Schwartz LH et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994; 12: 2277-83.
11. Cooper MA, Einhorn LH. Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors. J Clin Oncol 1995; 13: 1167-9.
12. Broun ER, Nichols GR, Kneebone P et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992; 117: 124-8.
13. Motzer RJ, Mazumdar M, Bosl GJ et al. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J Clin Oncol 1996; 14: 1098-105.
14. Hainsworth JD, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol 1992; 19: 119-27.
15. Nichols CR, Saxman S, Willians SD et al. Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience. Cancer 1991; 65: 1641-6.
16. Toner GC, Geller NL, Lin SY et al. Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features. Cancer 1991; 67: 2049-57.
17. Ulbright T, Loehrer P, Roth L et al. The development of non-germ cell malignancies within germ cell tumors. A clinocopathologic study in 11 cases. Cancer 1984; 54: 1824-33.
18. Motzer RJ, Rodriguez E, Reuter V et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 1995; 13: 274-82.
19. Kiffer JD, Sandeman TF et al. Primary malignant mediastinal germ cell tumors: A study of eleven cases and review of the literature. Int J Radiat Oncol Biol Phys 1989; 17: 835-41.
20. Childs WJ, Goldstraw P, Nicholls JE et al. Primary malignant mediastinal germ cell tumours: Improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer 1993; 67: 1098-101.
21. Logothetis CJ, Samuels ML, Selig DE et al. Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1986; 3: 316-25.
22. Bukowski RM, Wolf M, Kulander B et al. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest oncology group study. Cancer 1993; 71: 2631-8.
23. Harding MJ, Paul J, Gillis CR et al. Management of malignant teratoma: Does referral to a specialist unit matter? Lancet 1993; 341: 999-1002.
24. Saxman SB, Nichols CR, Einhorn LH et al. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 1994; 12: 1390-3.
25. Beyer J, Kramar A, Mandanas R et al. High-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT): A multivariate analysis of prognostic variables. J Clin Oncol 1996; 14: 2638-45.
26. Hainsworth JD, Einhorn LH, Willians SD et al. Advanced extragonadal germ cell tumors. Ann Intern Med 1987; 97: 7-11.
27. Ladanyi M, Samaniego F, Reuter VE et al. Cytogenetic and Inmunohistochemical evidence for the germ cell origen of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 1990; 82: 221-7.
28. Gerl A, Clemm C, Lamerz R et al. Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience. Cancer 1996; 77: 526-32.
29. Goss PE, Schwertfeger L, Blackstein M et al. Extragonadal germ cell tumors. A 14 year Toronto experience. Cancer 1994; 73: 1971-9.